Company Information

MAX HEALTHCARE INSTITUTE LTD.

NSE : MAXHEALTHBSE : 543220ISIN CODE : INE027H01010Industry : Hospital & Healthcare ServicesHouse : Max
BSE812.9552.6 (+6.92 %)
PREV CLOSE ( ) 760.35
OPEN PRICE ( ) 773.95
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 63737
TODAY'S LOW / HIGH ( )762.25 816.65
52 WK LOW / HIGH ( )435.1 909
NSE811.0050.4 (+6.63 %)
PREV CLOSE( ) 760.60
OPEN PRICE ( ) 772.00
BID PRICE (QTY) 811.00 (1250)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 3118514
TODAY'S LOW / HIGH( ) 760.60 816.70
52 WK LOW / HIGH ( )435.05 910
ChairmanAbhay Soi
Managing DirectorAbhay Soi
Company SecretaryDhiraj Aroraa
Non Executive DirectorAnil Bhatnagar
Narayan K Seshadri
Non Executive Independent DirectorK Narasimha Murthy
Mahendra Gumanmalji Lodha
Michael Thomas Neeb
Pranav Amin
Amrita Gangotra
Director - ProjectsVaradhan Moorthy
Incorporation Year :

Registered Office :

Address : 401, 4th Floor, Man Excellenza,S. V. Road,Vile Parle (West) Mumbai,
Maharashtra-400056 .

Phone : 022-26101035

Industry : Hospital & Healthcare Services

Listing : BSE,NSE

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.